288 related articles for article (PubMed ID: 19855174)
1. Cancer vaccines and immunotherapy.
Tang H
Hum Vaccin; 2009 Oct; 5(10):666. PubMed ID: 19855174
[No Abstract] [Full Text] [Related]
2. Cancer vaccines: what do we need to measure in clinical trials?
Kudrin A
Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for cancer: focusing on developing treatments rather than drugs.
Sznol M
Curr Opin Investig Drugs; 2001 Jul; 2(7):957-8. PubMed ID: 11757798
[No Abstract] [Full Text] [Related]
4. Increasing immunogenicity of cancer vaccines to improve their clinical outcome.
Parmiani G; Cimminiello C; Maccalli C
Expert Rev Vaccines; 2013 Oct; 12(10):1111-3. PubMed ID: 24124873
[No Abstract] [Full Text] [Related]
5. Cancer vaccines 2000.
Tartour E; Fridman WH
Immunol Lett; 2000 Sep; 74(1):1-3. PubMed ID: 10996621
[No Abstract] [Full Text] [Related]
6. Cancer vaccines: toward the next revolution in cancer therapy.
Emens LA
Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776
[No Abstract] [Full Text] [Related]
7. Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
Berzofsky JA; Wood LV; Terabe M
Expert Rev Vaccines; 2013 Oct; 12(10):1115-8. PubMed ID: 24124874
[No Abstract] [Full Text] [Related]
8. [New directions in immunotherapy for malignant solid tumors].
Okuno K; Sugiura F; Sukegawa Y; Inoue K
Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
[TBL] [Abstract][Full Text] [Related]
9. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
Nelson B
Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
[No Abstract] [Full Text] [Related]
10. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
[No Abstract] [Full Text] [Related]
11. MUC1 as a target antigen for cancer immunotherapy.
Acres B; Limacher JM
Expert Rev Vaccines; 2005 Aug; 4(4):493-502. PubMed ID: 16117706
[TBL] [Abstract][Full Text] [Related]
12. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
13. Prevention is better than cure: the case for clinical trials of therapeutic cancer vaccines in the prophylactic setting.
Gray A; Yan L; Kast WM
Mol Interv; 2010 Aug; 10(4):197-203. PubMed ID: 20729485
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in therapeutic cancer vaccines.
Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
[TBL] [Abstract][Full Text] [Related]
15. The fourth pillar: Despite some setbacks in the clinic, immunotherapy has made notable progress toward becoming an additional therapeutic option against cancer.
Hunter P
EMBO Rep; 2017 Nov; 18(11):1889-1892. PubMed ID: 29021204
[TBL] [Abstract][Full Text] [Related]
16. Rekindling cancer vaccines.
Branca MA
Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
[No Abstract] [Full Text] [Related]
17. Therapeutic cancer vaccines: From initial findings to prospects.
Song Q; Zhang CD; Wu XH
Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
[TBL] [Abstract][Full Text] [Related]
18. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
[TBL] [Abstract][Full Text] [Related]
19. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
Aldous AR; Dong JZ
Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
Fournier P; Schirrmacher V
Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]